| EP2702172 - METHOD FOR DETERMINING CLINICALLY RELEVANT HYPOXIA IN CANCER [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 06.11.2020 Database last updated on 28.03.2026 | |
| Former | The patent has been granted Status updated on 05.12.2019 | ||
| Former | Grant of patent is intended Status updated on 16.07.2019 | ||
| Former | Examination is in progress Status updated on 27.01.2017 | Most recent event Tooltip | 29.07.2022 | Lapse of the patent in a contracting state New state(s): FR | published on 31.08.2022 [2022/35] | Applicant(s) | For all designated states Aarhus Universitet Nordre Ringgade 1 8000 Aarhus C / DK | [2015/01] |
| Former [2014/10] | For all designated states Overgaard, Jens Strandvejen 134 8000 Aarhus C / DK | ||
| For all designated states Sørensen, Brita Singers Højager 1 8530 Hjortshøj / DK | |||
| For all designated states Alsner, Jan Hjulbjergvej 48C 8270 Højbjerg / DK | |||
| For all designated states Wiuf, Carsten Serridslevvej 16 3.4 2100 København Ø / DK | |||
| For all designated states Nordsmark, Marianne Fortebakken 9 8240 Risskov / DK | |||
| For all designated states Toustrup, Kasper P.S. Krøyers Vej 30 8270 Højbjerg / DK | Inventor(s) | 01 /
Overgaard, Jens Strandvejen 134 8000 Århus C / DK | 02 /
Sørensen, Brita Singers Højager 1 8530 Hjortshøj / DK | 03 /
Toustrup, Kasper P.S. Krøyers Vej 30 8270 Højbjerg / DK | 04 /
Alsner, Jan Hjulbjergvej 48C 8270 Højbjeg / DK | 05 /
Wiuf, Carsten Serridslevvej 16, 3.4 2100 København Ø / DK | 06 /
Nordsmark, Marianne Fortebakken 9 8240 Risskov / DK | [2020/01] |
| Former [2015/01] | 01 /
Overgaard, Jens Strandvejen 134 8000 Århus C / DK | ||
| 02 /
Sørensen, Brita Singers Højager 1 8530 Hjortshøj / DK | |||
| 03 /
Toustrup, Kasper P.S. Krøyers Vej 30 8270 Højbjerg / DK | |||
| 04 /
Alsner, Jan Hjulbjergvej 48C 8270 Højbjeg / DK | |||
| 05 /
Wiuf, Carsten Serridslevvej 16 3.4 2100 København Ø / DK | |||
| 06 /
Nordsmark, Marianne Fortebakken 9 8240 Risskov / DK | |||
| Former [2014/10] | 01 /
see applicant ... | Representative(s) | Høiberg P/S Adelgade 12 1304 Copenhagen K / DK | [2020/01] |
| Former [2014/10] | Høiberg A/S St. Kongensgade 59 A 1264 Copenhagen K / DK | Application number, filing date | 12724283.2 | 30.04.2012 | [2020/01] | WO2012DK50144 | Priority number, date | DK20110070212 | 29.04.2011 Original published format: DK 201170212 | [2014/10] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2012146259 | Date: | 01.11.2012 | Language: | EN | [2012/44] | Type: | A1 Application with search report | No.: | EP2702172 | Date: | 05.03.2014 | Language: | EN | The application published by WIPO in one of the EPO official languages on 01.11.2012 takes the place of the publication of the European patent application. | [2014/10] | Type: | B1 Patent specification | No.: | EP2702172 | Date: | 01.01.2020 | Language: | EN | [2020/01] | Search report(s) | International search report - published on: | EP | 01.11.2012 | Classification | IPC: | C12Q1/6886 | [2019/27] | CPC: |
C12Q1/6886 (EP,US);
A61K31/5377 (EP,US);
A61K45/06 (US);
A61N5/10 (US);
A61P35/00 (EP);
A61P43/00 (EP);
G01N33/4925 (US);
A61N2005/1098 (US);
C12Q2600/106 (EP,US);
|
| Former IPC [2014/10] | C12Q1/68, A61K31/415, A61K31/4164 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/10] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | VERFAHREN ZUR BESTIMMUNG VON KLINISCH RELEVANTER HYPOXIE BEI KREBS | [2014/10] | English: | METHOD FOR DETERMINING CLINICALLY RELEVANT HYPOXIA IN CANCER | [2014/10] | French: | MÉTHODE DE DÉTERMINATION DE LA PRÉSENCE D'UNE HYPOXIE CLINIQUEMENT PERTINENTE EN CAS DE CANCER | [2014/10] | Entry into regional phase | 29.11.2013 | National basic fee paid | 29.11.2013 | Designation fee(s) paid | 29.11.2013 | Examination fee paid | Examination procedure | 29.11.2013 | Examination requested [2014/10] | 20.06.2014 | Amendment by applicant (claims and/or description) | 30.01.2017 | Despatch of a communication from the examining division (Time limit: M06) | 09.08.2017 | Reply to a communication from the examining division | 17.07.2019 | Communication of intention to grant the patent | 22.11.2019 | Fee for grant paid | 22.11.2019 | Fee for publishing/printing paid | 22.11.2019 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 30.01.2017 | Opposition(s) | 02.10.2020 | No opposition filed within time limit [2020/50] | Fees paid | Renewal fee | 28.04.2014 | Renewal fee patent year 03 | 08.04.2015 | Renewal fee patent year 04 | 18.04.2016 | Renewal fee patent year 05 | 20.04.2017 | Renewal fee patent year 06 | 24.10.2018 | Renewal fee patent year 07 | 26.04.2019 | Renewal fee patent year 08 | Penalty fee | Additional fee for renewal fee | 30.04.2018 | 07   M06   Fee paid on   24.10.2018 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 30.04.2012 | AL | 01.01.2020 | AT | 01.01.2020 | CY | 01.01.2020 | CZ | 01.01.2020 | EE | 01.01.2020 | ES | 01.01.2020 | FI | 01.01.2020 | HR | 01.01.2020 | IT | 01.01.2020 | LT | 01.01.2020 | LV | 01.01.2020 | MC | 01.01.2020 | MK | 01.01.2020 | MT | 01.01.2020 | NL | 01.01.2020 | PL | 01.01.2020 | RO | 01.01.2020 | RS | 01.01.2020 | SE | 01.01.2020 | SI | 01.01.2020 | SK | 01.01.2020 | SM | 01.01.2020 | TR | 01.01.2020 | BG | 01.04.2020 | NO | 01.04.2020 | GR | 02.04.2020 | BE | 30.04.2020 | CH | 30.04.2020 | FR | 30.04.2020 | GB | 30.04.2020 | IE | 30.04.2020 | LI | 30.04.2020 | LU | 30.04.2020 | IS | 01.05.2020 | PT | 27.05.2020 | [2022/35] |
| Former [2022/31] | HU | 30.04.2012 | |
| AL | 01.01.2020 | ||
| AT | 01.01.2020 | ||
| CY | 01.01.2020 | ||
| CZ | 01.01.2020 | ||
| EE | 01.01.2020 | ||
| ES | 01.01.2020 | ||
| FI | 01.01.2020 | ||
| HR | 01.01.2020 | ||
| IT | 01.01.2020 | ||
| LT | 01.01.2020 | ||
| LV | 01.01.2020 | ||
| MC | 01.01.2020 | ||
| MK | 01.01.2020 | ||
| MT | 01.01.2020 | ||
| NL | 01.01.2020 | ||
| PL | 01.01.2020 | ||
| RO | 01.01.2020 | ||
| RS | 01.01.2020 | ||
| SE | 01.01.2020 | ||
| SI | 01.01.2020 | ||
| SK | 01.01.2020 | ||
| SM | 01.01.2020 | ||
| TR | 01.01.2020 | ||
| BG | 01.04.2020 | ||
| NO | 01.04.2020 | ||
| GR | 02.04.2020 | ||
| BE | 30.04.2020 | ||
| CH | 30.04.2020 | ||
| GB | 30.04.2020 | ||
| IE | 30.04.2020 | ||
| LI | 30.04.2020 | ||
| LU | 30.04.2020 | ||
| IS | 01.05.2020 | ||
| PT | 27.05.2020 | ||
| Former [2022/30] | HU | 30.04.2012 | |
| AL | 01.01.2020 | ||
| AT | 01.01.2020 | ||
| CY | 01.01.2020 | ||
| CZ | 01.01.2020 | ||
| EE | 01.01.2020 | ||
| ES | 01.01.2020 | ||
| FI | 01.01.2020 | ||
| HR | 01.01.2020 | ||
| IT | 01.01.2020 | ||
| LT | 01.01.2020 | ||
| LV | 01.01.2020 | ||
| MC | 01.01.2020 | ||
| MT | 01.01.2020 | ||
| NL | 01.01.2020 | ||
| PL | 01.01.2020 | ||
| RO | 01.01.2020 | ||
| RS | 01.01.2020 | ||
| SE | 01.01.2020 | ||
| SI | 01.01.2020 | ||
| SK | 01.01.2020 | ||
| SM | 01.01.2020 | ||
| TR | 01.01.2020 | ||
| BG | 01.04.2020 | ||
| NO | 01.04.2020 | ||
| GR | 02.04.2020 | ||
| BE | 30.04.2020 | ||
| CH | 30.04.2020 | ||
| GB | 30.04.2020 | ||
| IE | 30.04.2020 | ||
| LI | 30.04.2020 | ||
| LU | 30.04.2020 | ||
| IS | 01.05.2020 | ||
| PT | 27.05.2020 | ||
| Former [2022/27] | HU | 30.04.2012 | |
| AT | 01.01.2020 | ||
| CY | 01.01.2020 | ||
| CZ | 01.01.2020 | ||
| EE | 01.01.2020 | ||
| ES | 01.01.2020 | ||
| FI | 01.01.2020 | ||
| HR | 01.01.2020 | ||
| IT | 01.01.2020 | ||
| LT | 01.01.2020 | ||
| LV | 01.01.2020 | ||
| MC | 01.01.2020 | ||
| MT | 01.01.2020 | ||
| NL | 01.01.2020 | ||
| PL | 01.01.2020 | ||
| RO | 01.01.2020 | ||
| RS | 01.01.2020 | ||
| SE | 01.01.2020 | ||
| SI | 01.01.2020 | ||
| SK | 01.01.2020 | ||
| SM | 01.01.2020 | ||
| TR | 01.01.2020 | ||
| BG | 01.04.2020 | ||
| NO | 01.04.2020 | ||
| GR | 02.04.2020 | ||
| BE | 30.04.2020 | ||
| CH | 30.04.2020 | ||
| GB | 30.04.2020 | ||
| IE | 30.04.2020 | ||
| LI | 30.04.2020 | ||
| LU | 30.04.2020 | ||
| IS | 01.05.2020 | ||
| PT | 27.05.2020 | ||
| Former [2022/26] | AT | 01.01.2020 | |
| CZ | 01.01.2020 | ||
| EE | 01.01.2020 | ||
| ES | 01.01.2020 | ||
| FI | 01.01.2020 | ||
| HR | 01.01.2020 | ||
| IT | 01.01.2020 | ||
| LT | 01.01.2020 | ||
| LV | 01.01.2020 | ||
| MC | 01.01.2020 | ||
| NL | 01.01.2020 | ||
| PL | 01.01.2020 | ||
| RO | 01.01.2020 | ||
| RS | 01.01.2020 | ||
| SE | 01.01.2020 | ||
| SI | 01.01.2020 | ||
| SK | 01.01.2020 | ||
| SM | 01.01.2020 | ||
| TR | 01.01.2020 | ||
| BG | 01.04.2020 | ||
| NO | 01.04.2020 | ||
| GR | 02.04.2020 | ||
| BE | 30.04.2020 | ||
| CH | 30.04.2020 | ||
| GB | 30.04.2020 | ||
| IE | 30.04.2020 | ||
| LI | 30.04.2020 | ||
| LU | 30.04.2020 | ||
| IS | 01.05.2020 | ||
| PT | 27.05.2020 | ||
| Former [2021/22] | AT | 01.01.2020 | |
| CZ | 01.01.2020 | ||
| EE | 01.01.2020 | ||
| ES | 01.01.2020 | ||
| FI | 01.01.2020 | ||
| HR | 01.01.2020 | ||
| IT | 01.01.2020 | ||
| LT | 01.01.2020 | ||
| LV | 01.01.2020 | ||
| MC | 01.01.2020 | ||
| NL | 01.01.2020 | ||
| PL | 01.01.2020 | ||
| RO | 01.01.2020 | ||
| RS | 01.01.2020 | ||
| SE | 01.01.2020 | ||
| SI | 01.01.2020 | ||
| SK | 01.01.2020 | ||
| SM | 01.01.2020 | ||
| BG | 01.04.2020 | ||
| NO | 01.04.2020 | ||
| GR | 02.04.2020 | ||
| BE | 30.04.2020 | ||
| CH | 30.04.2020 | ||
| GB | 30.04.2020 | ||
| IE | 30.04.2020 | ||
| LI | 30.04.2020 | ||
| LU | 30.04.2020 | ||
| IS | 01.05.2020 | ||
| PT | 27.05.2020 | ||
| Former [2021/20] | AT | 01.01.2020 | |
| CZ | 01.01.2020 | ||
| EE | 01.01.2020 | ||
| ES | 01.01.2020 | ||
| FI | 01.01.2020 | ||
| HR | 01.01.2020 | ||
| IT | 01.01.2020 | ||
| LT | 01.01.2020 | ||
| LV | 01.01.2020 | ||
| MC | 01.01.2020 | ||
| NL | 01.01.2020 | ||
| PL | 01.01.2020 | ||
| RO | 01.01.2020 | ||
| RS | 01.01.2020 | ||
| SE | 01.01.2020 | ||
| SI | 01.01.2020 | ||
| SK | 01.01.2020 | ||
| SM | 01.01.2020 | ||
| BG | 01.04.2020 | ||
| NO | 01.04.2020 | ||
| GR | 02.04.2020 | ||
| BE | 30.04.2020 | ||
| CH | 30.04.2020 | ||
| IE | 30.04.2020 | ||
| LI | 30.04.2020 | ||
| LU | 30.04.2020 | ||
| IS | 01.05.2020 | ||
| PT | 27.05.2020 | ||
| Former [2021/10] | AT | 01.01.2020 | |
| CZ | 01.01.2020 | ||
| EE | 01.01.2020 | ||
| ES | 01.01.2020 | ||
| FI | 01.01.2020 | ||
| HR | 01.01.2020 | ||
| IT | 01.01.2020 | ||
| LT | 01.01.2020 | ||
| LV | 01.01.2020 | ||
| MC | 01.01.2020 | ||
| NL | 01.01.2020 | ||
| PL | 01.01.2020 | ||
| RO | 01.01.2020 | ||
| RS | 01.01.2020 | ||
| SE | 01.01.2020 | ||
| SI | 01.01.2020 | ||
| SK | 01.01.2020 | ||
| SM | 01.01.2020 | ||
| BG | 01.04.2020 | ||
| NO | 01.04.2020 | ||
| GR | 02.04.2020 | ||
| BE | 30.04.2020 | ||
| CH | 30.04.2020 | ||
| LI | 30.04.2020 | ||
| LU | 30.04.2020 | ||
| IS | 01.05.2020 | ||
| PT | 27.05.2020 | ||
| Former [2021/08] | CZ | 01.01.2020 | |
| EE | 01.01.2020 | ||
| ES | 01.01.2020 | ||
| FI | 01.01.2020 | ||
| HR | 01.01.2020 | ||
| LT | 01.01.2020 | ||
| LV | 01.01.2020 | ||
| MC | 01.01.2020 | ||
| NL | 01.01.2020 | ||
| RO | 01.01.2020 | ||
| RS | 01.01.2020 | ||
| SE | 01.01.2020 | ||
| SK | 01.01.2020 | ||
| SM | 01.01.2020 | ||
| BG | 01.04.2020 | ||
| NO | 01.04.2020 | ||
| GR | 02.04.2020 | ||
| CH | 30.04.2020 | ||
| LI | 30.04.2020 | ||
| LU | 30.04.2020 | ||
| IS | 01.05.2020 | ||
| PT | 27.05.2020 | ||
| Former [2020/52] | CZ | 01.01.2020 | |
| EE | 01.01.2020 | ||
| ES | 01.01.2020 | ||
| FI | 01.01.2020 | ||
| HR | 01.01.2020 | ||
| LT | 01.01.2020 | ||
| LV | 01.01.2020 | ||
| MC | 01.01.2020 | ||
| NL | 01.01.2020 | ||
| RO | 01.01.2020 | ||
| RS | 01.01.2020 | ||
| SE | 01.01.2020 | ||
| SK | 01.01.2020 | ||
| SM | 01.01.2020 | ||
| BG | 01.04.2020 | ||
| NO | 01.04.2020 | ||
| GR | 02.04.2020 | ||
| IS | 01.05.2020 | ||
| PT | 27.05.2020 | ||
| Former [2020/50] | CZ | 01.01.2020 | |
| EE | 01.01.2020 | ||
| ES | 01.01.2020 | ||
| FI | 01.01.2020 | ||
| HR | 01.01.2020 | ||
| LT | 01.01.2020 | ||
| LV | 01.01.2020 | ||
| NL | 01.01.2020 | ||
| RO | 01.01.2020 | ||
| RS | 01.01.2020 | ||
| SE | 01.01.2020 | ||
| SK | 01.01.2020 | ||
| SM | 01.01.2020 | ||
| BG | 01.04.2020 | ||
| NO | 01.04.2020 | ||
| GR | 02.04.2020 | ||
| IS | 01.05.2020 | ||
| PT | 27.05.2020 | ||
| Former [2020/49] | CZ | 01.01.2020 | |
| ES | 01.01.2020 | ||
| FI | 01.01.2020 | ||
| HR | 01.01.2020 | ||
| LT | 01.01.2020 | ||
| LV | 01.01.2020 | ||
| NL | 01.01.2020 | ||
| RO | 01.01.2020 | ||
| RS | 01.01.2020 | ||
| SE | 01.01.2020 | ||
| SK | 01.01.2020 | ||
| SM | 01.01.2020 | ||
| BG | 01.04.2020 | ||
| NO | 01.04.2020 | ||
| GR | 02.04.2020 | ||
| IS | 01.05.2020 | ||
| PT | 27.05.2020 | ||
| Former [2020/48] | CZ | 01.01.2020 | |
| ES | 01.01.2020 | ||
| FI | 01.01.2020 | ||
| HR | 01.01.2020 | ||
| LT | 01.01.2020 | ||
| LV | 01.01.2020 | ||
| NL | 01.01.2020 | ||
| RO | 01.01.2020 | ||
| RS | 01.01.2020 | ||
| SE | 01.01.2020 | ||
| SM | 01.01.2020 | ||
| BG | 01.04.2020 | ||
| NO | 01.04.2020 | ||
| GR | 02.04.2020 | ||
| IS | 01.05.2020 | ||
| PT | 27.05.2020 | ||
| Former [2020/40] | CZ | 01.01.2020 | |
| FI | 01.01.2020 | ||
| HR | 01.01.2020 | ||
| LT | 01.01.2020 | ||
| LV | 01.01.2020 | ||
| NL | 01.01.2020 | ||
| RS | 01.01.2020 | ||
| SE | 01.01.2020 | ||
| BG | 01.04.2020 | ||
| NO | 01.04.2020 | ||
| GR | 02.04.2020 | ||
| IS | 01.05.2020 | ||
| PT | 27.05.2020 | ||
| Former [2020/39] | CZ | 01.01.2020 | |
| FI | 01.01.2020 | ||
| HR | 01.01.2020 | ||
| LT | 01.01.2020 | ||
| LV | 01.01.2020 | ||
| NL | 01.01.2020 | ||
| RS | 01.01.2020 | ||
| SE | 01.01.2020 | ||
| BG | 01.04.2020 | ||
| NO | 01.04.2020 | ||
| GR | 02.04.2020 | ||
| PT | 27.05.2020 | ||
| Former [2020/38] | CZ | 01.01.2020 | |
| FI | 01.01.2020 | ||
| HR | 01.01.2020 | ||
| LT | 01.01.2020 | ||
| LV | 01.01.2020 | ||
| NL | 01.01.2020 | ||
| RS | 01.01.2020 | ||
| SE | 01.01.2020 | ||
| NO | 01.04.2020 | ||
| GR | 02.04.2020 | ||
| PT | 27.05.2020 | ||
| Former [2020/37] | CZ | 01.01.2020 | |
| FI | 01.01.2020 | ||
| HR | 01.01.2020 | ||
| LT | 01.01.2020 | ||
| LV | 01.01.2020 | ||
| NL | 01.01.2020 | ||
| RS | 01.01.2020 | ||
| SE | 01.01.2020 | ||
| NO | 01.04.2020 | ||
| PT | 27.05.2020 | ||
| Former [2020/36] | CZ | 01.01.2020 | |
| FI | 01.01.2020 | ||
| LT | 01.01.2020 | ||
| NL | 01.01.2020 | ||
| RS | 01.01.2020 | ||
| NO | 01.04.2020 | ||
| PT | 27.05.2020 | ||
| Former [2020/35] | CZ | 01.01.2020 | |
| FI | 01.01.2020 | ||
| LT | 01.01.2020 | ||
| NL | 01.01.2020 | ||
| NO | 01.04.2020 | ||
| Former [2020/33] | NL | 01.01.2020 | Cited in | International search | [A] WO2008154927 (GENMAB AS et al.) | [IY] BRITA SINGERS SRENSEN ET AL: "Identifying pH independent hypoxia induced genes in human squamous cell carcinomas in vitro", ACTA ONCOLOGICA, vol. 49, no. 7, 1 October 2010 (2010-10-01), pages 895 - 905, XP055011557, ISSN: 0284-186X, DOI: 10.3109/02841861003614343 DOI: http://dx.doi.org/10.3109/02841861003614343 | [XY] JENS OVERGAARD: "Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck - A systematic review and meta-analysis", RADIOTHERAPY AND ONCOLOGY, vol. 100, no. 1, 19 April 2011 (2011-04-19), pages 22 - 32, XP055011177, ISSN: 0167-8140, DOI: 10.1016/j.radonc.2011.03.004 DOI: http://dx.doi.org/10.1016/j.radonc.2011.03.004 | [XY] L. B. HARRISON: "Impact of Tumor Hypoxia and Anemia on Radiation Therapy Outcomes", THE ONCOLOGIST, vol. 7, no. 6, 1 December 2002 (2002-12-01), pages 492 - 508, XP055011170, ISSN: 1083-7159, DOI: 10.1634/theoncologist.7-6-492 DOI: http://dx.doi.org/10.1634/theoncologist.7-6-492 | [I] KELEG SHEREEN ET AL: "Adrenomedullin is induced by hypoxia and enhances pancreatic cancer cell invasion", INTERNATIONAL JOURNAL OF CANCER, JOHN WILEY & SONS, INC, US, vol. 121, 1 January 2007 (2007-01-01), pages 21 - 32, XP002496945, ISSN: 0020-7136, [retrieved on 20070208], DOI: 10.1002/IJC.22596 DOI: http://dx.doi.org/10.1002/ijc.22596 | [A] ROBERT G. BRISTOW ET AL: "Hypoxia and metabolism: Hypoxia, DNA repair and genetic instability", NATURE REVIEWS CANCER, vol. 8, no. 3, 1 March 2008 (2008-03-01), pages 180 - 192, XP055011090, ISSN: 1474-175X, DOI: 10.1038/nrc2344 DOI: http://dx.doi.org/10.1038/nrc2344 | Examination | K. TOUSTRUP ET AL: "Development of a Hypoxia Gene Expression Classifier with Predictive Impact for Hypoxic Modification of Radiotherapy in Head and Neck Cancer", CANCER RESEARCH, vol. 71, no. 17, 1 September 2011 (2011-09-01), pages 5923 - 5931, XP055011554, ISSN: 0008-5472, DOI: 10.1158/0008-5472.CAN-11-1182 [P] DOI: http://dx.doi.org/10.1158/0008-5472.CAN-11-1182 | by applicant | MOON ET AL.: "The potential role of intrinsic hypoxia markers as prognostic variables in cancer", ANTIOXID REDOX SIGNAL, vol. 9, 2007, pages 1237 - 1294 | CHI ET AL.: "Gene expression programs in response to hypoxia: Cell type specificity and prognostic significance in human cancers", PLOS MED, vol. 3, 2006, pages E47 | WINTER ET AL.: "Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers", CANCER RES, vol. 67, 2007, pages 3441 - 3449 | BUFFA ET AL.: "Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene", BR J CANCER, vol. 102, 2010, pages 428 - 435 | SMITH; WATERMAN, ADV. APPL. MATH., vol. 2, 1981, pages 482 | NEEDLEMAN; WUNSCH, J. MOL. BIOL., vol. 48, 1970, pages 443 | PEARSON; LIPMAN, PROC. NATL. ACAD. SCI. (U.S.A., vol. 85, 1988, pages 2444 | M. KANEHISA, NUCLEIC ACIDS RES., vol. 12, 1984, pages 203 | SAMBROOK ET AL.: "Molecular Cloning: A Laboratory Manual", vol. 1-3, 1989, COLD SPRING HARBOR LABORATORY | "Current Protocols in Molecular Biology", 1987, GREENE PUBLISHING AND WILEY-INTERSCIENCE | "Remington: The Science and Practice of Pharmacy", 2000, LIPPINCOTT WILLIAMS & WILKINS | REMINGTON'S PHARMACEUTICAL SCIENCES, 1980 |